Business Context and Reporting Period
This April 24, 2020 Form 8-K was filed by Social Capital Hedosophia Holdings Corp. III, a special purpose acquisition company (SPAC), not by Clover Health Investments, Corp. The filing reports the closing of the company’s initial public offering (IPO) and related private placement.
The company completed its IPO on April 24, 2020, including the underwriters’ full exercise of their over-allotment option. The filing does not identify an operating business or completed business combination.
Key Financial and Capitalization Metrics
| Item | Amount or terms |
|---|---|
| IPO units issued | 82,800,000 |
| IPO price | $10.00 per unit |
| Gross IPO proceeds | $828.0 million |
| Private placement warrants | 10,933,333 warrants at $1.50 each |
| Private placement gross proceeds | $16.4 million |
| Trust account deposit | $828.0 million, comprising proceeds from the IPO and private placement |
| Warrant exercise price | $11.50 per share, subject to adjustment |
| Revenue, profit, margins and operating cash flow | The filing does not provide operating results or clear values for these metrics. |
| Debt and liquidity | No debt balance or detailed liquidity schedule is provided. IPO-related funds were placed in a U.S.-based trust account. |
Material Changes Versus the Prior Comparable Period
The filing reports the company’s initial public offering and therefore does not present a prior comparable operating period. The principal change was the creation of substantial cash resources held in trust and the issuance of public shares, units and warrants.
Guidance, Outlook, Risks and Unusual Items
- The trust account funds generally cannot be released until the earliest of completion of an initial business combination, certain permitted shareholder redemptions, or redemption of public shares if no business combination is completed within 24 months of the IPO closing.
- Interest earned on trust-account funds may be released to pay taxes, if any.
- The company’s public warrants are exercisable for shares at $11.50 per share, subject to adjustment.
- Private placement warrants have different transfer, redemption and exercise provisions while held by the sponsor, including potential cashless exercise and registration rights.
- The filing provides no financial guidance, revenue outlook or management forecast.
- Completion of a future business combination, shareholder redemption rights and the 24-month completion deadline are significant contingencies for investors.
Important Facts to Verify
- Verify that the relevant registrant is Social Capital Hedosophia Holdings Corp. III rather than Clover Health Investments, Corp.
- Confirm the $828.0 million trust-account deposit and the treatment of the $16.4 million private placement proceeds.
- Review the trust agreement and amended organizational documents for redemption rights and the 24-month business-combination deadline.
- Review the warrant agreement for exercise, redemption and adjustment provisions.
- Confirm that the filing contains no operating financial statements, profitability data, debt schedule or business-combination announcement.